ArticleFrontiers in medicine2026
Simultaneous LC-MS/MS quantification of free deoxyguanosines 2'-dG and 8-OHdG in ovine seminal plasma as biomarkers of oxidative DNA damage.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oxidative stress is harmful for spermatic DNA, since high levels of reactive oxygen species lead to the formation of toxic adducts derived from DNA oxidation. This phenomenon is especially relevant under pathological conditions such as asthenozoospermia, necrozoospermia, oligozoospermia, or azoospermia. The nucleoside most susceptible to this damage is 2'-deoxyguanosine (2'-dG), which is oxidized to form 8-hydroxy-2'-deoxyguanosine (8-OHdG), one of the most widely studied biomarkers of oxidative stress. Previous studies have reported an increased liberation of cell-free DNA during impaired spermatogenesis and cellular necrosis, supporting the presence of free nucleosides in seminal plasma under altered physiological conditions. Consequently, the determination of both biomarkers not only provides information about the oxidative status, but also about cellular turnover. The aim of this study was, therefore, to develop, validate, and apply a reliable and complete analytical methodology for the simultaneous quantification of the mentioned biomarkers in ovine seminal plasma by solid phase extraction (SPE) off-line LC-MS/MS. The procedure includes the study and development of the SPE-based sample preparation protocol, as well as the optimization of instrumental parameters, including the description of the fragmentation pathways for both analytes and the internal standard. Validation followed US FDA guidelines for bioanalytical methods, fulfilling acceptance criteria for precision, linearity response, LOD and LOQ, recoveries, and matrix effect. In addition, sustainability was assessed in accordance with two green analytical chemistry metrics (GAPI and AGREE). The proposed method was applied to seminal plasma extracted from three healthy -pooled sample- and one ram with low sperm quality (LQ)-absence of sperm motility and severely low sperm concentration-. Both 2'-dG and 8-OHdG levels were markedly elevated in the affected ram, with approximately two-fold and four-fold increase, respectively. These promising preliminary results align with the proof-of-concept design of the study. This analytically validated approach represents the first SPE off-line LC-MS/MS method for the simultaneous quantification of free 2'-dG and 8-OHdG in seminal plasma, providing a robust analytical framework for future studies exploring these nucleosides as complementary biomarkers of oxidative DNA with potential applicability to human andrology upon validation in clinical cohorts.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.